StemX Synergies LLC holds a provisional patent (filed April 4, 2025 for a novel method in stem cell research. we co-culture male and female stem cells from diverse functional zones of the human body to analyze their synergistic reactions, complementary interactions, and regulatory impacts. this approach aims to unlock new potentials in regeneration and DNA repair, offering hope for advanced treatments in regenerative medicine. We're seeking research partners to validate and scale this innovation-join us in shaping the future of biotech.